Terron Alexis is a New York, New York based nurse practitioner. Active license number of Terron Alexis is F404102-01 for Psych/Mental Health in New York. His current practice location is 99 Hudson St Fl 4, New York. Patients can reach him at 855-444-7258 and his NPI number (Unique professional ID assigned by NPPES) is 1740785773. Terron Alexis has completed additional training beyond basic nursing education and provides primary health care services in accordance with state nurse practice laws or statutes. NPs are trained to assess patient needs, order and interpret diagnostic and laboratory tests, diagnose disease, formulate and prescribe medications and treatment plans.
Complete Profile:
Terron Alexis speciality, credentials, practice address, contact phone number and fax are as below.
Patients can call on the below given phone number for appointment.
NPI number stands for National Provider Identifier which is a unique 10-digit identification number issued to health care providers in the United States by the Centers for Medicare and Medicaid Services (CMS).
NPI details are as mentioned below.
NPI Number:
1740785773
NPI Enumeration Date:
30 Mar, 2018
NPI Last Update On:
01 Sep, 2022
Medical Licenses:
NPs can have one or more medical licenses for different specialities in the same state or different states. Related medical licenses for Terron Alexis are as mentioned below.
License Number
Specialization
State
Status
F404102-01
Psych/Mental Health
New York
Primary
737804
Registered Nurse
New York
Secondary
Business Mailing Address:
Business mailing address can be used for mailing purpose only, for visiting purpose patients need to refer above mentioned address.
Address:
Terron Alexis 202 E 55th St Apt 2r, Brooklyn, New York
Zip:
11203-3751
Phone Number:
347-260-7642
Patients can reach Terron Alexis at 99 Hudson St Fl 4, New York, New York or can call to book an appointment on 855-444-7258.
Comments/ Reviews:
Data of this site is collected from Medicare & Medicaid Services (CMS) and NPPES. Last updated on 13 January, 2025.